Suppliers / Haleon Ireland Dungarvan

Haleon Ireland Dungarvan

Ireland Updated 9 July 2026

Haleon Ireland Dungarvan is a finished-dose manufacturer based in Ireland. It appears in 165 regulatory filings across 13 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY), FAMHP (BE) and EDE (AE). Its GMP standing is certified by EMA, ANVISA (Brazil) and US FDA, among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 23 August 2024 as VAI.

0
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
165
filings across 13 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 23 August 2024 VAI US FDA
  • 10 June 2016 NAI US FDA
  • 13 September 2013 NAI US FDA
  • 22 September 2011 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Dungarvan, United Arab Emirates Not on file
DUNGARVAN, Ireland Not on file
Co. Waterford, Ireland Not on file
Ireland, Ireland 3003721894

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 109 None
FAMHP (BE) 10 None
EDE (AE) 10 None
AEMPS (ES) 10 None
AIFA (IT) 10 None
EMA 4 2
ANVISA (Brazil) None 2
US FDA None 1
NCELS (KZ) None 1

Comparing suppliers?

Choose your molecules and target markets. Haleon Ireland Dungarvan comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 23 August 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates